In Silico Effects of Steviol on Depression, Inflammation and Cancer Biomarkers

被引:5
|
作者
Harismah, Kun [1 ]
Fazeli, Farzaneh [2 ]
Amini, Issa [3 ]
Da'i, Muhammad [4 ]
Mirzaei, Mahmoud [5 ]
机构
[1] Univ Muhammadiyah Surakarta, Fac Engn, Dept Chem Engn, Surakarta, Indonesia
[2] Payame Noor Univ, Dept Biol, Tehran, Iran
[3] Payame Noor Univ, Dept Chem, Tehran, Iran
[4] Univ Muhammadiyah Surakarta, Fac Pharm, Dept Pharmaceut Biotechnol, Surakarta, Indonesia
[5] Isfahan Univ Med Sci, Biosensor Res Ctr, Sch Adv Technol Med, Esfahan, Iran
来源
BIOINTERFACE RESEARCH IN APPLIED CHEMISTRY | 2022年 / 12卷 / 06期
关键词
steviol; depression; inflammation; cancer; molecular docking; in silico; BINDING;
D O I
10.33263/BRIAC126.83858393
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Steviol (ST1), a known natural product, and methylated models (ST2-ST4) were investigated in this in silico work to see their effects were examined on each of depression, inflammation, and cancer biomarkers by participating in interactions with each of monoamine oxidase-A (MAO-A), cyclooxygenase-2 (COX-2), methyltransferase (MTN) enzymes, respectably. The stabilized structures of ST1-ST4 were achieved by performing optimization calculations. Subsequently, formations of interacting ligand-target complexes were examined by molecular docking (MD) simulations. The evaluated molecular orbital features showed a different tendency of ST1-ST4 models for contributing to electron transfer processes. Accordingly, the interacting ligand-target complexes showed differential interactions of each ligand towards each target, making ST1-ST4 as appropriate compounds for the detection of targets. The methylated ST2-ST4 models worked even better than the original ST1 model to affirm the benefit of steviol modification to achieve desired results. Meaningful interactions of ST1-ST4 with the targets also showed the possible application of steviol for the medication of each of depression, inflammation, and cancer cases.
引用
收藏
页码:8385 / 8393
页数:9
相关论文
共 50 条
  • [41] Crosstalk Between Inflammation and Glutamate System in Depression: Signaling Pathway and Molecular Biomarkers for Ketamine’s Antidepressant Effect
    Wenyan Cui
    Yuping Ning
    Wu Hong
    Ju Wang
    Zhening Liu
    Ming D. Li
    Molecular Neurobiology, 2019, 56 : 3484 - 3500
  • [42] Inflammation: an important parameter in the search of prostate cancer biomarkers
    Stefania Bergamini
    Elisa Bellei
    Luca Reggiani Bonetti
    Emanuela Monari
    Aurora Cuoghi
    Francesco Borelli
    Maria Chiara Sighinolfi
    Giampaolo Bianchi
    Tomris Ozben
    Aldo Tomasi
    Proteome Science, 12
  • [43] A Longitudinal Analysis of Inflammation and Depression in Patients With Metastatic Lung Cancer: Associations With Survival
    McFarland, Daniel C.
    Miller, Andrew H.
    Nelson, Christian
    BIOLOGICAL RESEARCH FOR NURSING, 2021, 23 (03) : 301 - 310
  • [44] Effects of atorvastatin on biomarkers of inflammation in chronic kidney disease
    Fassett, Robert G.
    Robertson, Iain K.
    Ball, Madeleine J.
    Geraghty, Dominic P.
    Coombes, Jeff S.
    CLINICAL NEPHROLOGY, 2014, 81 (02) : 75 - 85
  • [45] Crosstalk Between Inflammation and Glutamate System in Depression: Signaling Pathway and Molecular Biomarkers for Ketamine's Antidepressant Effect
    Cui, Wenyan
    Ning, Yuping
    Hong, Wu
    Wang, Ju
    Liu, Zhening
    Li, Ming D.
    MOLECULAR NEUROBIOLOGY, 2019, 56 (05) : 3484 - 3500
  • [46] Does inflammation mediate the effects of depression on heart disease? That may depend on the symptoms
    Carney, Robert M.
    Freedland, Kenneth E.
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2022, 152
  • [48] Inflammation and Response to ECT in Depression
    Kruse, Jennifer
    Congdon, Eliza
    Njau, Stephanie
    Breen, Elizabeth
    Olmstead, Richard
    Narr, Katherine
    Espinoza, Randall
    Irwin, Michael
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 : S519 - S520
  • [49] Effects of Physical Exercise on Depressive Symptoms and Biomarkers in Depression
    Archer, Trevor
    Josefsson, Torbjorn
    Lindwall, Magnus
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2014, 13 (10) : 1640 - 1653
  • [50] Inflammation, Heart Disease, and Depression
    Angelos Halaris
    Current Psychiatry Reports, 2013, 15